Saturday, 31 January 2015
Last updated 1 day ago
Sep 17 2012 | 1:37pm ET
A healthcare hedge fund had a second quarter it won't soon forget, jumping more than a quarter on the period.
Palo Alto Investors rose 26.2% between April and June, Insider Monkey reports. The surge is thanks in no small part to Palo Alto's largest holding, Onyx Pharmaceuticals, which makes up almost 17% of the hedge fund's portfolio and which is up 74.5% this year.
Palo Alto also profited from its stakes in Cyberonics Inc.
Jan 23 2015 | 1:00pm ET
In our new section, FINtech Focus, we will profile one of these firms each week. While fintech is a broad category, we will be focusing on firms that specifically cater to the alternative investment industry. Read more…